Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-10

Clinical Trial Update: Voclosporin in Adolescent and Pediatric Subjects With Lupus Nephritis [Phase 3]

View source ↗

Summary

A phase 3 trial of voclosporin in adolescent and pediatric lupus nephritis has been terminated. The study was sponsored by Aurinia Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Voclosporin (voclosporin)

Snippet

Sponsor: Aurinia Pharmaceuticals Inc. | Conditions: Adolescent Lupus Nephritis, Pediatric Lupus Nephritis | Phase 3 | Status: TERMINATED